Your browser doesn't support javascript.
loading
[Humanized BCMA CAR-T cell salvage therapy in two refractory multiple myeloma patients who progressed after their murine BCMA CAR-T cell therapy].
Cui, R; Li, P; Li, Q; Mu, J; Jiang, Y L; Jiang, Y Y; Deng, Q.
Afiliação
  • Cui R; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin 300192, China.
  • Li P; Department of Hematology, Dezhou People's Hospital, Shandong 253000, China.
  • Li Q; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin 300192, China.
  • Mu J; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin 300192, China.
  • Jiang YL; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin 300192, China.
  • Jiang YY; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin 300192, China.
  • Deng Q; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin 300192, China.
Zhonghua Xue Ye Xue Za Zhi ; 42(6): 502-507, 2021 Jun 14.
Article em Zh | MEDLINE | ID: mdl-34384157
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Limite: Animals / Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Limite: Animals / Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2021 Tipo de documento: Article